Market Research Logo

RSP Systems AS - Product Pipeline Analysis, 2019 Update

Summary

RSP Systems AS (RSP Systems) is a non-invasive diagnostic company that focuses on the development of pain-free glucose monitoring devices for diabetes management. The company advanced the technological application of Raman spectroscopy to measure various substances in human tissue in a non-invasive manner. It collects Raman signal from the interstitial fluid and cells selectively and analyzes spectral data to ascertain the concentration of such substances through the skin. Its other potential applications encompass measurement of alcohol and lactate. RSP Systems is a spinoff from the Biophotonics Group at the University of Southern Denmark. The company works in collaboration with Odense University Hospital for conducting clinical studies. RSP Systems is headquartered in Odense, Denmark.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company RSP Systems AS
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


RSP Systems AS Company Overview
RSP Systems AS Company Snapshot
RSP Systems AS Pipeline Products and Ongoing Clinical Trials Overview
RSP Systems AS – Pipeline Analysis Overview
RSP Systems AS - Key Facts
RSP Systems AS - Major Products and Services
RSP Systems AS Pipeline Products by Development Stage
RSP Systems AS Ongoing Clinical Trials by Trial Status
RSP Systems AS Pipeline Products Overview
3rd Generation GlucoBeam
3rd Generation GlucoBeam Product Overview
GlucoBeam
GlucoBeam Product Overview
GlucoBeam Clinical Trial
Prototype 0.5
Prototype 0.5 Product Overview
Prototype 0.5 Clinical Trial
RSP Systems AS - Key Competitors
RSP Systems AS - Key Employees
RSP Systems AS - Locations And Subsidiaries
Head Office
Recent Developments
RSP Systems AS, Recent Developments
Feb 19, 2019: RSP Systems to exhibit its cutting-edge non-invasive glucose monitor, GlucoBeam at ATTD 2019
Nov 03, 2016: RSP Systems awarded EUR2.4 million grant for GlucoBeam by the European Union's Horizon 2020 framework
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
RSP Systems AS Pipeline Products and Ongoing Clinical Trials Overview
RSP Systems AS Pipeline Products by Equipment Type
RSP Systems AS Pipeline Products by Indication
RSP Systems AS Ongoing Clinical Trials by Trial Status
RSP Systems AS, Key Facts
RSP Systems AS, Major Products and Services
RSP Systems AS Number of Pipeline Products by Development Stage
RSP Systems AS Pipeline Products Summary by Development Stage
RSP Systems AS Ongoing Clinical Trials by Trial Status
RSP Systems AS Ongoing Clinical Trials Summary
3rd Generation GlucoBeam - Product Status
3rd Generation GlucoBeam - Product Description
GlucoBeam - Product Status
GlucoBeam - Product Description
GlucoBeam - Proof-of- concept for Glucose Measurement in Diabetic Persons Using GlucoBeam
Prototype 0.5 - Product Status
Prototype 0.5 - Product Description
Prototype 0.5 - A Pilot Study of a Novel Non-invasive Glucose Monitoring Device
RSP Systems AS, Key Employees
Glossary
List of Figures
RSP Systems AS Pipeline Products by Equipment Type
RSP Systems AS Pipeline Products by Development Stage
RSP Systems AS Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report